FDA Inspection 1193409 — Citus Research LLP
The FDA completed an inspection of Citus Research LLP on December 9, 2022 in Gandhinagar. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 9, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gandhinagar (India)
Additional Details
Clinical BA/BE